Cintas Forecast, price target & analysts
Cintas Target price 2025 - Analyst rating & recommendation
Cintas Classifications & Recommendation:
Cintas Price Target
| Target Price | $212.69 |
| Price | $208.67 |
| Potential | 1.93% |
| Number of Estimates | 13 |
| 13 Analysts have issued a price target Cintas 2026 . The average Cintas target price is $212.69. This is 1.93% higher than the current stock price. The highest price target is $245.00 17.41% , the lowest is $163.00 21.89% . | |
| A rating was issued by 20 analysts: 6 Analysts recommend Cintas to buy, 10 to hold and 4 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Cintas stock has an average upside potential 2026 of 1.93% . Most analysts recommend the Cintas stock at Hold. |
Sales and Margin forecast 2025, 2026 to 2028
14 Analysts have issued a sales forecast Cintas 2025 . The average Cintas sales estimate is $10.3b . This is 1.53% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $10.3b 1.69% , the lowest is $10.3b 1.42% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $9.6b | 8.86% |
|---|---|---|
| 2025 | $10.3b | 7.31% |
| 2026 | $11.0b | 7.08% |
| 2027 | $11.8b | 6.80% |
| 2028 | $12.7b | 7.77% |
14 Analysts have issued an Cintas EBITDA forecast 2025. The average Cintas EBITDA estimate is $2.9b . This is 2.22% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $3.0b 6.98% , the lowest is $2.8b 0.67% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $2.5b | 13.53% |
|---|---|---|
| 2025 | $2.9b | 13.86% |
| 2026 | $3.1b | 8.34% |
| 2027 | $3.3b | 7.91% |
| 2028 | $3.7b | 10.68% |
EBITDA Margin
| 2024 | 26.17% | 4.29% |
|---|---|---|
| 2025 | 27.76% | 6.09% |
| 2026 | 28.09% | 1.19% |
| 2027 | 28.38% | 1.03% |
| 2028 | 29.15% | 2.71% |
8 Cintas Analysts have issued a net profit forecast 2025. The average Cintas net profit estimate is $1.8b . This is 1.77% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $1.8b 2.09% , the lowest is $1.8b 1.62% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $1.5b | 16.62% |
|---|---|---|
| 2025 | $1.8b | 15.73% |
| 2026 | $1.9b | 9.72% |
| 2027 | $2.1b | 7.34% |
Net Margin
| 2024 | 15.94% | 7.13% |
|---|---|---|
| 2025 | 17.19% | 7.83% |
| 2026 | 17.62% | 2.50% |
| 2027 | 17.71% | 0.51% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
8 Analysts have issued a Cintas forecast for earnings per share. The average Cintas EPS is $4.39 . This is 1.86% higher than earnings per share in the financial year 2024. The highest EPS forecast is $4.40 2.09% , the lowest is $4.38 1.62% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $3.79 | 16.62% |
|---|---|---|
| 2025 | $4.39 | 15.83% |
| 2026 | $4.81 | 9.57% |
| 2027 | $5.17 | 7.48% |
P/E ratio
| Current | 48.37 | 2.02% |
|---|---|---|
| 2025 | 47.57 | 1.65% |
| 2026 | 43.36 | 8.85% |
| 2027 | 40.39 | 6.85% |
Based on analysts' sales estimates for 2025, the Cintas stock is valued at an EV/Sales of 8.41 and an P/S ratio of 8.18 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 8.54 | 11.34% |
|---|---|---|
| 2025 | 8.41 | 1.47% |
| 2026 | 7.86 | 6.62% |
| 2027 | 7.36 | 6.37% |
| 2028 | 6.83 | 7.21% |
P/S ratio
| Current | 8.30 | 12.17% |
|---|---|---|
| 2025 | 8.18 | 1.50% |
| 2026 | 7.64 | 6.62% |
| 2027 | 7.15 | 6.37% |
| 2028 | 6.63 | 7.21% |
Current Cintas Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Mar 27 2025 |
| UBS |
Buy
➜
Buy
|
Unchanged | Mar 27 2025 |
| Baird |
Neutral
➜
Neutral
|
Unchanged | Mar 27 2025 |
| Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Mar 27 2025 |
| Truist Securities |
Buy
➜
Buy
|
Unchanged | Mar 27 2025 |
| Wells Fargo |
Underweight
➜
Underweight
|
Unchanged | Mar 27 2025 |
| RBC Capital |
Sector Perform
➜
Sector Perform
|
Unchanged | Mar 27 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
Mar 27 2025 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Mar 27 2025 |
|
Unchanged
Baird:
Neutral
➜
Neutral
|
Mar 27 2025 |
|
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Mar 27 2025 |
|
Unchanged
Truist Securities:
Buy
➜
Buy
|
Mar 27 2025 |
|
Unchanged
Wells Fargo:
Underweight
➜
Underweight
|
Mar 27 2025 |
|
Unchanged
RBC Capital:
Sector Perform
➜
Sector Perform
|
Mar 27 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
